Similarly with our findings, EIF3D was found to be up-regulated in recent studies in other cancer types including prostate cancer [89], non-small cell lung cancer [90], colon cancer [91], breast cancer [92], renal cell carcinomas [93], melanomas [94] and gliomas [95]. Here, EIF3D is linked to non-small cell lung carcinoma.